Choosing wisely when prescribing statins

• Published in: Nederlands tijdschrift voor geneeskunde Vol. 159; p. A8695
• Main Authors: Willemsen, Annelieke E C A B, Bredie, S J H Bas, Lobo, Claudia M, van der Vlugt, Maureen J, Kramers, C
• Format: Journal Article
• Language: Dutch
• Published: Netherlands 2015
• Subjects: Atorvastatin Calcium; Cardiovascular Diseases - drug therapy; Fluorobenzenes - economics; Fluorobenzenes - pharmacokinetics; Fluorobenzenes - therapeutic use; Health Care Costs; Heptanoic Acids - economics; Heptanoic Acids - pharmacokinetics; Heptanoic Acids - therapeutic use; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors - economics; Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacokinetics; Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use; Pyrimidines - economics; Pyrimidines - pharmacokinetics; Pyrimidines - therapeutic use; Pyrroles - economics; Pyrroles - pharmacokinetics; Pyrroles - therapeutic use; Quality of Health Care; Risk Factors; Rosuvastatin Calcium; Simvastatin - economics; Simvastatin - pharmacokinetics; Simvastatin - therapeutic use; Sulfonamides - economics; Sulfonamides - pharmacokinetics; Sulfonamides - therapeutic use

The Dutch campaign 'Verstandig kiezen', based on the American programme 'Choosing wisely', aims to improve quality in healthcare, with attention to cost control. The 'Choosing wisely'-based programme can be applied in the choice of a statin. Atorvastatin and rosuvastati...